+351 211 369 829 INFO@OPHIOMICS.COM

Ophiomics wins the EIC Accelerator Pilot scheme

Ophiomics wins EIC accelerator funding in its pilot scheme. This hybrid funding scheme that includes a grant together with investment from the European Investment Bank, will permit Ophiomics to take HepatoPredcit to market and make a difference in selecting the right patients cancer for liver transplantation.

Share the Post:

Related Posts

Thinking Big!

Ophiomics is now participating in the IPOready program by Euronext. This is a great opportunity to consider the best strategy

Read More